esophageal carcinoma
Conditions
Interventions
RP group:Radiotherapy
NRP group:Radiotherapy
Sponsors
Department of Oncology, the First Affiliated Hospital, Henan University of Science and Technology, Luoyang, China
Eligibility
Sex/Gender
All
Age
41 Years to 79 Years
Inclusion criteria
Inclusion criteria: Patients were diagnosed with esophageal cancer by biopsy or cytology; Patients did not undergo surgery and chemotherapy; All study participants are signed informed consent and are willingto participate in this study; Kamofsky performance status (KPS)>=80, age==6 months.
Exclusion criteria
Exclusion criteria: A history of radiotherapy or chemotherapy for thoracic tumor; A history of severe pulmonary dysfunction or pulmonary fibrosis; Patients who accepted whole or part of pulmonary lobectomy; Patients with poor general condition,leading to intolerance to radiation or given up halfway; Patients diagnosed with asthma, serious chronic bronchitis, emphysema, severe pulmonary infection and other serious diseases, such as myocardial infarction and cerebral infarction occurred within six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transforming growth factor ß1;Interleukin-1;Angiotensin-converting enzyme;C-reactive protein; | — |
Countries
China
Contacts
Public ContactShegan Gao
the First Affiliated Hospital, Henan University of Science and Technology
Outcome results
None listed